Transcatheter Mitral Valve Replacement Market Share, Size, Emerging Trends and Growth

Market Reports Center
One Stop Market Reaserch Shop
Transcatheter Mitral Valve Replacement Market Share, Size, Emerging
Trends and Growth, Analysis, Overview and Forecasts 2016-2020
Technavio Announces the Publication of its Research Report – Global Transcatheter Mitral Valve
Replacement Market 2016-2020
Technavio recognizes the following companies as the key players in the global transcatheter mitral valve
replacement market: Abbott Laboratories, Edwards Lifesciences, Micro Interventional Devices, and
Neovasc.
Other Prominent Vendors in the market are MitrAssist, NaviGate Cardiac Structures, and Valtech.
Commenting on the report, an analyst from Technavio’ s team said that the development of novel
products will promote growth for this market. Advances in technology, material, and design of
prosthetic valves and delivery devices have led surgeons to perform mitral valve replacement
procedures with better post-surgical outcomes. The growing focus on compatibility and durability of
implants in the human body led cardiologists to prefer transcatheter mitral valves to mechanical
prosthetic valves. The shift from open-heart procedures to minimally invasive methods for the
implantation of devices since 2005 has been a breakthrough in the demand and sales of heart valves.
Browse full report with TOC@ https://marketreportscenter.com/reports/344097/global-transcathetermitral-valve-replacement-market-2016-2020
According to the report, prevalence of mitral regurgitation is one of the drivers that led to the growth of
this market. Mitral regurgitation is a common heart valve disorder that affects 2%-3% of the population
worldwide. The disorder is becoming prevalent among all age groups rapidly. About 0.5% of individuals
aged 18-45 and 9% of people aged 60-75 have this disorder. In 2009, research studies estimated that
more than 176 million people worldwide have the disorder. These studies also estimated that more than
four million individuals in the US had mitral regurgitation. Of this number, about one in 10 individuals
was aged 75 and above.
Market Reports Center
One Stop Market Reaserch Shop
Further, the report states that availability of alternative treatment is negatively affecting the sales of
transcatheter mitral valve implants. Transcatheter mitral valve replacement is a minimally invasive
surgical procedure. This procedure has been proven to be safe and efficient, improving the quality of
life. However, mitral valve repair surgical procedures are medical consultants' first choice for treating
mitral regurgitation. Mitral valve repair surgery involves the implantation of a stent-like device for
reshaping the posterior region of the annulus to repair the damaged mitral valve. The surgical procedure
offers better postoperative left ventricular function, lowers long-term morbidity, and increases life
expectancy compared to transcatheter mitral valve replacement procedure. Cardiac Dimensions'
Carillon and Edwards Lifesciences' Monarc are two major mitral valve repair devices available in the
market. These devices are less expensive compared to transcatheter mitral valve replacement devices.
The study was conducted using an objective combination of primary and secondary information
including inputs from key participants in the industry. The report contains a comprehensive market and
vendor landscape in addition to a SWOT analysis of the key vendors.
Request A Sample copy of This Report @ https://marketreportscenter.com/request-sample/344097
About Mitral Valve
The mitral valve manages blood flow from the left atrium to the left ventricle. The valve prevents the
backward flow of the blood. Mitral regurgitation is a common mitral valve disorder that causes the
abnormal backward flow of the blood. Cardiologists use mitral surgical valve repair procedures or
transcatheter replacement procedures to treat this disorder. About 80,000 individuals undergo these
two procedures for treating the disorder.
Technavio’ s analysts forecast the global transcatheter mitral valve replacement market to grow at a
CAGR of 21.93% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global transcatheter mitral valve
replacement market for 2016-2020. To calculate the market size, the report considers the revenue
generated from the sales of transcatheter mitral valve implants.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Transcatheter Mitral Valve Replacement Market 2016-2020, has been
prepared based on an in-depth market analysis with inputs from industry experts. The report covers the
market landscape and its growth prospects over the coming years. The report also includes a discussion
of the key vendors operating in this market.
Market Reports Center
One Stop Market Reaserch Shop
To Get Discount On The Report @ https://marketreportscenter.com/request-discount/344097
Connect for more details:
Sam Collins
Market Reports Center
1-646-883-3044 (US)
[email protected]